Disclosure: Bullpen receives compensation from Timbercreek Financial for research coverage. Timbercreek is also an IR client of LodeRock Advisors, an affiliate of Bullpen.
|
|
||||
|
|
||||
|
|
||||
|
|
WHAT'S ON TAP
HOT OFF THE PRESS
H&R deal gets rejected
After a busy few months the H&R REIT deal is officially dead, with unitholders voting against the transaction - resulting in a retroactive distribution, future special, CEO/board refresh, and a focus on selling its industrial footprint…

… which makes sense, given it represents sub-20% of the company’s net real estate assets and the category has seen strong demand in recent years.

With earnings set to come after the close today, we’ll see what the go-forward plan is for H&R’s residential and office assets…

… and how it plans to handle GO REIT’s ~$102M lawsuit (termination fee).

CanGen’s £1.2B wealth sale and go-private
Canaccord Genuity (CF) announced Sunday that it finalized a deal to sell its UK wealth business for £1.2B to Centerbridge and Mubadala, ending a year-long process…

… and moving roughly a quarter of CF’s revenue to growth-focused hands, with Mubadala acquiring CI for $12B last year.

Subsequent to the close of that deal, CanGen’s Chairman and CEO looks to be taking the remaining business private…

… in a transaction valuing the total equity at $15.27 per share, a skinny 3% premium which could get bigger (45 day go-shop)…

… but likely not by much, given the deal multiple sits two turns above CF’s long-term average. Let’s see what happens.
TF Q3: Vancouver risk looks mispriced
Timbercreek Financial (TF) reported a challenging Q3 due to its Vancouver exposure, which took $33M of ECLs and should put temporary pressure on distributable income…

… while management pushes a sale of the main asset (Granville block) towards a Q1/27 close, giving it capital to redeploy into what’s a healthy origination backdrop.

With no firm deal in place yet, our base case now assumes a temporary distribution cut in Q2 - which should be restored as redeployed capital begins to produce…

… given MICs like TF pay out all income to shareholders by design, as it results in zero tax burden. We’re not sure investors get this dynamic, with shares moving down 14%…

… resulting in a market-implied impairment of $219M or 37% dividend cut to $0.43 per share. That compares to $190M of total staged loans (net) and $0.51 of DI per share on the current performing book…

… and is materially worse than our revised base case, which results in a book value per share >50% above current prices even with $27M more impairment - as we explore in the full report below:
Manufacturing sales hold steady at $80B
Manufacturing sales of $80B in September were flat M/M, with mixed performance at the sector level…

… led by petroleum product sales, which rose 10% on higher prices and offset 5-10% declines in both primary metals and wood.

Energy was the main driver of inventories too, which rose ~2% to $131B…

… while backlog grew by a similar amount on the back of unfilled orders in aerospace and computer & electronic products.

ON OUR RADAR
GAINERS & LOSERS
|
|
||||
|
|
||||
|
|
Stantec (STN) closed up 14% on solid Q3 results, which beat small on revenue thanks to growth in the company’s energy and water businesses…

… and beat bigger on profit, with record EBITDA of $377M driven by 150 bps of sequential margin expansion…

… which drove a positive revision to margin and EPS guidance for 2026.

With Stantec’s buildings, water, and energy segments pushing the backlog over $9B (13 months of work)…

… and a leverage profile that sits well below managements 2x ceiling…

… there’s plenty of room for organic growth, M&A, and share buybacks going forward - which could drive a re-rate given the stock has struggled over the past year.

Was this forwarded to you? Join 10,000+ investors reading The Morning Meeting by clicking the button below.




